BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29665787)

  • 1. Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.
    Wei M; Mao S; Lu G; Li L; Lan X; Huang Z; Chen Y; Zhao M; Zhao Y; Xia Q
    BMC Cancer; 2018 Apr; 18(1):434. PubMed ID: 29665787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells.
    Juengel E; Dauselt A; Makarević J; Wiesner C; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
    Cancer Lett; 2012 Nov; 324(1):83-90. PubMed ID: 22579787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.
    Juengel E; Makarević J; Tsaur I; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
    PLoS One; 2013; 8(1):e53100. PubMed ID: 23372654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma.
    Zhang X; Zhang X; Huang T; Geng J; Liu M; Zheng J
    Int J Clin Exp Pathol; 2015; 8(3):2823-8. PubMed ID: 26045790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Treatment with Valproic Acid and 5-Aza-2'-Deoxycytidine Synergistically Inhibits Human Clear Cell Renal Cell Carcinoma Growth and Migration.
    Xi W; Chen X; Sun J; Wang W; Huo Y; Zheng G; Wu J; Li Y; Yang A; Wang T
    Med Sci Monit; 2018 Feb; 24():1034-1043. PubMed ID: 29457966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
    Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
    Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
    Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
    Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation.
    Miranda-Gonçalves V; Lameirinhas A; Macedo-Silva C; Lobo J; C Dias P; Ferreira V; Henrique R; Jerónimo C
    Cells; 2020 Apr; 9(4):. PubMed ID: 32340156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line.
    Yagi Y; Fushida S; Harada S; Kinoshita J; Makino I; Oyama K; Tajima H; Fujita H; Takamura H; Ninomiya I; Fujimura T; Ohta T; Yashiro M; Hirakawa K
    J Exp Clin Cancer Res; 2010 Nov; 29(1):149. PubMed ID: 21080974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
    Kanao K; Mikami S; Mizuno R; Shinojima T; Murai M; Oya M
    J Urol; 2008 Sep; 180(3):1131-6. PubMed ID: 18639283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits ACHN cells via regulation of histone acetylation.
    Dai L; Chen L; Wang W; Lin P
    Pharm Biol; 2020 Dec; 58(1):231-238. PubMed ID: 32202448
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
    Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
    Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro.
    Juengel E; Engler J; Mickuckyte A; Jones J; Hudak L; Jonas D; Blaheta RA
    BJU Int; 2010 Feb; 105(4):549-57. PubMed ID: 19594733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrix.
    Jones J; Juengel E; Mickuckyte A; Hudak L; Wedel S; Jonas D; Hintereder G; Blaheta RA
    J Cell Mol Med; 2009 Aug; 13(8B):2342-2352. PubMed ID: 19067765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo.
    Jones J; Juengel E; Mickuckyte A; Hudak L; Wedel S; Jonas D; Blaheta RA
    J Cell Mol Med; 2009 Aug; 13(8B):2376-2385. PubMed ID: 18657224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
    Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
    BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.
    Hudak L; Tezeeh P; Wedel S; Makarević J; Juengel E; Tsaur I; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
    Prostate; 2012 Dec; 72(16):1719-35. PubMed ID: 22473339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Gene Expression by Sodium Valproate in Epithelial-to-Mesenchymal Transition.
    Noguchi S; Eitoku M; Moriya S; Kondo S; Kiyosawa H; Watanabe T; Suganuma N
    Lung; 2015 Oct; 193(5):691-700. PubMed ID: 26286207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway.
    Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q
    Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histone Deacetylation Down-regulates the Expression of
    Liu JB; Wang HZ; Liu ZH; Xu M; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):384-388. PubMed ID: 28616911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.